Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy (2015)
- Authors:
- USP affiliated authors: BARUFFI, MARCELO DIAS - FCFRP ; TURATO, WALTER MIGUEL - FCF ; SILVA, CELIO LOPES - FMRP ; RAMOS, SIMONE GUSMÃO - FMRP ; ARRUDA, LUISA KARLA DE PAULA - FMRP ; MARTINS, VANIA LUIZA DEPERON BONATO - FMRP ; RUSSO, MOMTCHILO - ICB
- Unidades: FCFRP; FCF; FMRP; ICB
- DOI: 10.1111/all.12555
- Subjects: ANTI-HISTAMÍNICOS H1; ALERGIA E IMUNOLOGIA; IMUNOTERAPIA
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2015
- Source:
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FONSECA, Denise Morais da et al. Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy. Allergy, v. 70, n. 3, p. 275-284, 2015Tradução . . Disponível em: https://doi.org/10.1111/all.12555. Acesso em: 19 set. 2024. -
APA
Fonseca, D. M. da, Wowk, P. F., Paula, M. O., Gembre, A. F., Baruffi, M. D., Fermino, M. L., et al. (2015). Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy. Allergy, 70( 3), 275-284. doi:10.1111/all.12555 -
NLM
Fonseca DM da, Wowk PF, Paula MO, Gembre AF, Baruffi MD, Fermino ML, Turato WM, Campos LW, Silva CL, Ramos SG, Horn C, Marchal G, Arruda LK de P, Russo M, Bonato VLD. Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy [Internet]. Allergy. 2015 ; 70( 3): 275-284.[citado 2024 set. 19 ] Available from: https://doi.org/10.1111/all.12555 -
Vancouver
Fonseca DM da, Wowk PF, Paula MO, Gembre AF, Baruffi MD, Fermino ML, Turato WM, Campos LW, Silva CL, Ramos SG, Horn C, Marchal G, Arruda LK de P, Russo M, Bonato VLD. Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy [Internet]. Allergy. 2015 ; 70( 3): 275-284.[citado 2024 set. 19 ] Available from: https://doi.org/10.1111/all.12555 - IFN-'gama'-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN
- Mycobacterium tuberculosis culture filtrate proteins plus CpG oligodeoxynucleotides confer protection to mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion
- Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway
- Experimental asthma induced by Tropomyosins from cockroach and shrimp: insights into in vivo cross-reactivity
- M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection
- Attenuation of experimental asthma by mycobacterial protein combined with CpG requires a TLR9-dependent IFN-γ-CCR2 signalling circuit
- Endogenous versus esogenous antigens presentation for protection against tuberculosis
- Protection conferred by heterologous vaccination against tuberculosis is dependent on the ratio of CD4+/ CD4+ Foxp3+ cells
- Th1 polarized response induced by intramuscular DNA-HSP65 immunization is preserved in experimental atherosclerosis
- Genetic aspects and microenvironment affects expression of CD18 and VLA-4 in experimental tuberculosis
Informações sobre o DOI: 10.1111/all.12555 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
